| |
|
|
|
|
|
|
|||
|
Blood, 15 April 2007, Vol. 109, No. 8, pp. 3139-3146. Prepublished online as a Blood First Edition Paper on December 14, 2006; DOI 10.1182/blood-2006-10-052787.
PLENARY PAPER Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor1 Robarts Research Institute, London, ON, Canada; 2 Department of Surgery and 3 Department of Microbiology and Immunology, University of Western Ontario, London, ON, Canada; 4 Department of Pharmacology, Georgetown University, Washington, DC
Although typically considered a neurotransmitter, there is substantial evidence that serotonin (5-HT) plays an important role in the pathogenesis of inflammatory disorders. Despite these findings, the precise role of 5-HT in modulating immune function, particularly T-cell function, remains elusive. We report that naive T cells predominantly express the type 7 5-HT receptor (5-HTR), and expression of this protein is substantially enhanced on T-cell activation. In addition, T-cell activation leads to expression of the 5-HT1B and 5-HT2A receptors. Significantly, exogenous 5-HT induces rapid phosphorylation of extracellular signal-regulated kinase-1 and -2 (ERK1/2) and I
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||